Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging.
about
Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systemsThoracoscopy: medical versus surgical-in the management of pleural diseasesSize- and shape-dependent pleural translocation, deposition, fibrogenesis, and mesothelial proliferation by multiwalled carbon nanotubesIdentification of novel autoantibodies for detection of malignant mesotheliomaFactors that impact susceptibility to fiber-induced health effectsLength-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleuraCurrent issues in malignant pleural mesothelioma evaluation and managementAsbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesotheliomaA novel classification of lung cancer into molecular subtypesHyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.Novel systemic therapy against malignant pleural mesothelioma.Management of malignant pleural effusions.Inhibition of proliferation, migration, and matrix metalloprotease production in malignant mesothelioma cells by tyrosine kinase inhibitors.Pleural controversies: image guided biopsy vs. thoracoscopy for undiagnosed pleural effusions?Mesothelioma: a review.Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.Folylpoly-glutamate synthetase expression is associated with tumor response and outcome from pemetrexed-based chemotherapy in malignant pleural mesotheliomaMalignant mesothelioma of the pleura: interobserver variability.Semirigid thoracoscopy: an effective method for diagnosing pleural malignancies.Making the case for molecular staging of malignant pleural mesothelioma.Soluble markers for diagnosis of malignant pleural mesothelioma.Malignant pleural mesothelioma: when is radiation therapy indicated?Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy.BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.Malignant pleural mesothelioma: A retrospective analysis of clinicopathological and survival data.Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma.Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers.Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.Length-dependent pleural inflammation and parietal pleural responses after deposition of carbon nanotubes in the pulmonary airspaces of mice.Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.Staging in the era of international databases: documented improvements with remaining challenges.Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.Early-stage Clinical Characterization of Malignant Pleural MesotheliomaThe eighth TNM classification for malignant pleural mesothelioma
P2860
Q24679305-39623DC7-59DD-4435-BD36-C68E4A2322D6Q26774966-3064F81C-DA5B-41EF-AD7F-EADCC38FCFADQ28387346-38349AC7-5B24-4B00-B1EF-CD54B0EE40C9Q28387447-5B60389A-239E-4913-AD45-1D7A77BFDBF2Q28389535-76766725-D4B2-4007-9F9C-3216754F30FFQ28389843-BF79942E-8CF4-4A8F-948A-BC3FC24ECFD2Q28393560-2C63FDD7-E004-4C1D-AB15-6231168A4C0EQ28395017-8FF2265D-8F43-4D25-8AA9-E5DD994DAB21Q28731874-AE865FF0-B0AF-46EA-AF6B-7B071E8BAD95Q33373158-6ED15FA6-4F59-4266-8CB4-D097930ACDD2Q33890499-424D9817-3DEA-408B-BC86-9262EB2D3521Q33924596-72788DCB-BA25-4A85-824E-26A01CFC8D1BQ34928661-B713F441-7AD1-466A-9423-D0983ED6388EQ35739564-DB00F94B-A8D2-4705-B285-70289CFBD71DQ35839385-A05317ED-1F07-4C45-9D0B-1B852E54ACD7Q36136075-EC15CACF-67F2-44C7-AB40-D68808BEC799Q36821171-EBF22F3E-3B4C-479F-8A4E-F7A129E47DDCQ37267136-200EA267-8C9E-4311-8D41-4D611083D1E4Q37537898-CBE63AEA-559D-4603-A05D-2C5F44A24E08Q37613240-E68244F5-7672-4321-9181-6D5097A496FBQ37862752-7A574B8C-792B-4CE1-8A37-93C800004A98Q37866786-FD7366A1-0762-4617-9DFA-19A0B42C0FEBQ37975136-52401E17-B7B0-4D31-974C-B331850CD641Q38408709-265A234B-EB6A-477F-B8DF-21B6377C7335Q38843698-AAE66D9A-47E2-4FCE-80DC-EEF0CDA2FF50Q40041012-EEC4FE8C-E630-4F6A-9438-7D0D87E9DDBAQ40684793-3E5C02DF-AB54-4D48-A959-3DF4ACB2E376Q41118413-128981A2-219F-42DB-A827-47A5551A22DCQ43466291-58AB2149-6CE6-4AA5-8932-490654090806Q47367566-41C2AD44-E02D-4937-B7B7-7A43C92C2463Q50644560-E0CF7BEC-CCC9-444A-AFB3-F044D25F9295Q54991391-68C8433F-0238-4A51-95D8-42B3E2D4B3A7Q55113818-38C45F83-705A-44A5-BD98-A555699D1F2DQ58765920-FE08387D-0B93-4FAA-96F6-BE698D5E6A8CQ59137559-EE42C44B-D8EB-422D-A203-F722C538CD04
P2860
Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Thoracoscopy in pleural malign ...... Part 2: Prognosis and staging.
@en
Thoracoscopy in pleural malign ...... Part 2: Prognosis and staging.
@nl
type
label
Thoracoscopy in pleural malign ...... Part 2: Prognosis and staging.
@en
Thoracoscopy in pleural malign ...... Part 2: Prognosis and staging.
@nl
prefLabel
Thoracoscopy in pleural malign ...... Part 2: Prognosis and staging.
@en
Thoracoscopy in pleural malign ...... Part 2: Prognosis and staging.
@nl
P2093
P1433
P1476
Thoracoscopy in pleural malign ...... Part 2: Prognosis and staging.
@en
P2093
P304
P356
10.1002/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5
P407
P577
1993-07-01T00:00:00Z